DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Teradata Corp
TDC
Collegium Pharmaceutical
COLL
Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 4.62%6.55B | 0.62%6.32B | -3.92%6.95B | 2.65%25.38B | 0.54%5.6B | 5.16%6.26B | -6.31%6.29B | 11.41%7.24B | 12.64%24.73B | 7.73%5.57B |
Net interest income | 1.88%3.31B | -6.54%3.06B | 0.62%3.07B | 20.21%12.71B | ---- | 5.83%3.25B | 35.01%3.27B | 30.41%3.05B | 30.96%10.57B | ---- |
-Net interest income | 1.88%3.31B | 23.78%15.57B | 0.62%3.07B | 83.68%35.08B | ---- | 5.83%3.25B | 162.45%12.58B | 30.41%3.05B | 69.89%19.1B | ---- |
-Total interest expense | ---- | ---- | ---- | 162.39%22.37B | ---- | ---- | ---- | ---- | 169.15%8.52B | ---- |
Non interest income | 7.57%3.24B | 8.39%3.27B | -7.24%3.88B | -10.47%12.68B | ---- | 4.44%3.01B | -29.65%3.02B | 0.70%4.18B | 1.99%14.16B | ---- |
-Fees and commissions | 7.57%3.24B | 14.19%-1.6B | -7.24%3.88B | -3.20%4.42B | ---- | 4.44%3.01B | -1.53%-1.86B | 0.70%4.18B | 7.37%4.56B | ---- |
-Dividend income | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 55.00%31M | ---- |
Credit losses provision | ||||||||||
Non interest expense | ||||||||||
Selling and administrative expenses | ---- | ---- | ---- | 14.63%2.6B | ---- | ---- | ---- | ---- | 15.40%2.27B | ---- |
-General and administrative expense | ---- | ---- | ---- | 13.95%2.02B | ---- | ---- | ---- | ---- | 12.88%1.77B | ---- |
-Selling and marketing expense | ---- | ---- | ---- | 17.00%585M | ---- | ---- | ---- | ---- | 25.31%500M | ---- |
-Depreciation and amortization | ---- | ---- | ---- | 3.54%1.78B | ---- | ---- | ---- | ---- | 2.99%1.72B | ---- |
Income from associates and other participating interests | -250.00%-9M | -97.69%6M | ||||||||
Special income (charges) | -35M | -30.70%-149M | -5,800.00%-57M | 1.77%-1.56B | -2,144.12%-1.53B | 0 | 91.49%-114M | 100.19%1M | -44.71%-1.59B | 91.40%-68M |
Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | 6,557.14%452M | ---- | ---- | ---- | ---- | -102.36%-7M | ---- |
Less:Impairment of capital assets | ---- | ---- | ---- | 476.19%363M | ---- | ---- | ---- | ---- | -84.37%63M | ---- |
Less:Other special charges | --35M | -78.79%7M | 5,800.00%57M | -51.44%743M | 5,825.00%711M | ---- | -97.53%33M | -100.19%-1M | 285.39%1.53B | -86.96%12M |
Other non-operating income (expenses) | 133.33%21M | 340.00%12M | 1,000.00%9M | 50.00%-5M | ||||||
Income before tax | 18.41%2.23B | -1.32%1.94B | -12.36%2.28B | -6.49%6.56B | -91.60%110M | -4.27%1.89B | 31.02%1.96B | 16.29%2.6B | -14.43%7.01B | -8.26%1.31B |
Income tax | 20.12%412M | 20.96%427M | -17.11%465M | 18.77%1.23B | 30.30%-23M | 37.75%343M | 68.90%353M | -8.63%561M | -8.70%1.04B | -131.73%-33M |
Earnings from equity interest net of tax | ||||||||||
Net income | 18.03%1.82B | -6.21%1.51B | -11.05%1.81B | -10.88%5.32B | -90.10%133M | -10.35%1.54B | 24.88%1.61B | 25.74%2.04B | -15.35%5.97B | 1.44%1.34B |
Net Income continuous operations | 18.03%1.82B | -6.21%1.51B | -11.05%1.81B | -10.88%5.32B | -90.10%133M | -10.35%1.54B | 24.88%1.61B | 25.74%2.04B | -15.35%5.97B | 1.44%1.34B |
Minority interest income | -66.67%3M | 4.55%23M | -62.50%3M | 42.22%64M | 13.64%25M | 350.00%9M | 10.00%22M | 700.00%8M | -4.26%45M | -18.52%22M |
Net income attributable to the parent company | 18.53%1.82B | -6.36%1.49B | -10.84%1.81B | -11.29%5.26B | -91.82%108M | -10.77%1.53B | 25.12%1.59B | 25.32%2.03B | -15.42%5.93B | 1.85%1.32B |
Preferred stock dividends | ||||||||||
Other preferred stock dividend | -2.32%253M | -3.83%251M | 5.28%259M | 8.84%985M | -23.16%219M | 25.73%259M | 31.16%261M | 14.42%246M | 12.56%905M | 30.73%285M |
Net income attributable to common stockholders | 22.76%1.56B | -6.85%1.24B | -13.07%1.55B | -14.91%4.27B | -110.71%-111M | -15.74%1.27B | 24.00%1.33B | 26.99%1.78B | -19.05%5.02B | -3.99%1.04B |
Basic earnings per share | 28.92%0.428 | -3.49%0.332 | -8.85%0.412 | -10.06%1.108 | -107.58%-0.02 | -11.70%0.332 | 34.38%0.344 | 34.52%0.452 | -15.62%1.232 | 1.54%0.264 |
Diluted earnings per share | 28.92%0.428 | -2.78%0.332 | -8.85%0.412 | -9.73%1.076 | -111.23%-0.0293 | -11.70%0.332 | 33.39%0.3415 | 34.52%0.452 | -16.29%1.192 | 1.34%0.2611 |
Dividend per share | 7.22%0.1136 | 0 | -18.06%0.1675 | 26.24%0.3103 | 0 | 18.77%0.1059 | 0 | 30.50%0.2044 | 103.59%0.2458 | 0 |
Currency Unit | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |